N
MLTX icon

Nuveen’s MoonLake Immunotherapeutics MLTX Stock Holding History

Nuveen’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$623K Sell
33,417
-604,017
-95% -$10M ﹤0.01% 2760
2025
Q4 		$8.4M Buy
637,434
+1,735
+0.3% +$20.5K ﹤0.01% 1657
2025
Q3 		$4.56M Sell
635,699
-155,856
-20% -$8.12M ﹤0.01% 1950
2025
Q2 		$37.4M Buy
791,555
+118,212
+18% +$4.82M 0.01% 738
2025
Q1 		$26.3M Buy
673,343
+77,762
+13% +$3.35M 0.01% 950
2024
Q4 		$32.3M Buy
595,581
+14,792
+3% +$755K 0.01% 872
2024
Q3 		$29.3M Buy
580,789
+59,076
+11% +$2.77M 0.01% 943
2024
Q2 		$22.9M Buy
521,713
+325,842
+166% +$13.8M 0.01% 1040
2024
Q1 		$9.84M Sell
195,871
-444
-0.2% -$24.1K ﹤0.01% 1593
2023
Q4 		$11.9M Buy
196,315
+56,315
+40% +$2.9M ﹤0.01% 1485
2023
Q3 		$7.98M Hold
140,000
– – ﹤0.01% 1608
2023
Q2 		$7.14M Buy
+140,000
New +$3.77M ﹤0.01% 1712

Other funds holding MLTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return